EDBT 2026 Demo / reviewers in the wild / expert
Sofia Papadimitriou
dblp:252/1306
· DBLP profile ↗
3ranked-venue papers
0as first author
2since 2021 · last 2024
0000-0002-5057-4331ORCID · corroborated
Domains — the database's venue-derived domains; a paper can count in several
Applied, interdisciplinary, general and emerging computing · 2 · 2 since 2021Artificial intelligence and machine learning · 1
Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.
| Interdisciplinary, comprehensive, and emerging computing
1 paper |
Bioinformatics and computational biology · 100% |
Topics — the 3 heaviest of 3, each with the papers that count most for it
| Topic | Weight | Papers | Last | Evidence papers |
|---|---|---|---|---|
Bioinformatics and computational biology › knowledge representation in biology
biomedical knowledge graph |
0.8 | 1 | 2024 | Prioritization of oligogenic variant combinations in whole exomes · Bioinform. 2024 |
Bioinformatics and computational biology › statistical genetics › variant prioritization
genomic variant prioritization |
0.8 | 1 | 2024 | Prioritization of oligogenic variant combinations in whole exomes · Bioinform. 2024 |
Bioinformatics and computational biology
knowledge graph |
0.8 | 1 | 2024 | Prioritization of oligogenic variant combinations in whole exomes · Bioinform. 2024 |
Methods — techniques the papers use, named apart from their topics
pathogenicity prediction · 0.8knowledge graph · 0.8
| Year | Publication | Venue | Position |
|---|---|---|---|
| 2024 | Prioritization of oligogenic variant combinations in whole exomesabstractMOTIVATION: Whole exome sequencing (WES) has emerged as a powerful tool for genetic research, enabling the collection of a tremendous amount of data about human genetic variation. However, properly identifying which variants are causative of a genetic disease remains an important challenge, often due to the number of variants that need to be screened. Expanding the screening to combinations of variants in two or more genes, as would be required under the oligogenic inheritance model, simply blows this problem out of proportion. RESULTS: We present here the High-throughput oligogenic prioritizer (Hop), a novel prioritization method that uses direct oligogenic information at the variant, gene and gene pair level to detect digenic variant combinations in WES data. This method leverages information from a knowledge graph, together with specialized pathogenicity predictions in order to effectively rank variant combinations based on how likely they are to explain the patient's phenotype. The performance of Hop is evaluated in cross-validation on 36 120 synthetic exomes for training and 14 280 additional synthetic exomes for independent testing. Whereas the known pathogenic variant combinations are found in the top 20 in approximately 60% of the cross-validation exomes, 71% are found in the same ranking range when considering the independent set. These results provide a significant improvement over alternative approaches that depend simply on a monogenic assessment of pathogenicity, including early attempts for digenic ranking using monogenic pathogenicity scores. AVAILABILITY AND IMPLEMENTATION: Hop is available at https://github.com/oligogenic/HOP. Barbara Gravel, Alexandre Renaux, Sofia Papadimitriou, Guillaume Smits, Ann Nowé, Tom Lenaerts |
Bioinform. | 3 |
| 2023 | Faster and more accurate pathogenic combination predictions with VarCoPP2.0abstractBACKGROUND: The prediction of potentially pathogenic variant combinations in patients remains a key task in the field of medical genetics for the understanding and detection of oligogenic/multilocus diseases. Models tailored towards such cases can help shorten the gap of missing diagnoses and can aid researchers in dealing with the high complexity of the derived data. The predictor VarCoPP (Variant Combinations Pathogenicity Predictor) that was published in 2019 and identified potentially pathogenic variant combinations in gene pairs (bilocus variant combinations), was the first important step in this direction. Despite its usefulness and applicability, several issues still remained that hindered a better performance, such as its False Positive (FP) rate, the quality of its training set and its complex architecture. RESULTS: We present VarCoPP2.0: the successor of VarCoPP that is a simplified, faster and more accurate predictive model identifying potentially pathogenic bilocus variant combinations. Results from cross-validation and on independent data sets reveal that VarCoPP2.0 has improved in terms of both sensitivity (95% in cross-validation and 98% during testing) and specificity (5% FP rate). At the same time, its running time shows a significant 150-fold decrease due to the selection of a simpler Balanced Random Forest model. Its positive training set now consists of variant combinations that are more confidently linked with evidence of pathogenicity, based on the confidence scores present in OLIDA, the Oligogenic Diseases Database ( https://olida.ibsquare.be ). The improvement of its performance is also attributed to a more careful selection of up-to-date features identified via an original wrapper method. We show that the combination of different variant and gene pair features together is important for predictions, highlighting the usefulness of integrating biological information at different levels. CONCLUSIONS: Through its improved performance and faster execution time, VarCoPP2.0 enables a more accurate analysis of larger data sets linked to oligogenic diseases. Users can access the ORVAL platform ( https://orval.ibsquare.be ) to apply VarCoPP2.0 on their data. Nassim Versbraegen, Barbara Gravel, Charlotte Nachtegael, Alexandre Renaux, Emma Verkinderen, Ann Nowé, Tom Lenaerts, Sofia Papadimitriou |
BMC Bioinform. | 8 |
| 2019 | Using game theory and decision decomposition to effectively discern and characterise bi-locus diseases
Nassim Versbraegen, Aziz Fouché, Charlotte Nachtegael, Sofia Papadimitriou, Andrea M. Gazzo, Guillaume Smits, Tom Lenaerts |
Artif. Intell. Medicine | 4 |